| scholarly article | Q13442814 |
| P50 | author | Yasunori Tanji | Q42859425 |
| P2093 | author name string | N Kato | |
| K Shimotohno | |||
| M Hijikata | |||
| K Kimura | |||
| T Akagi | |||
| Y Komoda | |||
| H Mizushima | |||
| Y Hirowatari | |||
| P2860 | cites work | Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate-responsive gene that is highly expressed in an adult T-cell leukemia cell line | Q24655741 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Expression and identification of hepatitis C virus polyprotein cleavage products | Q27486022 | ||
| Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites | Q27486027 | ||
| Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions | Q27486051 | ||
| NS3 is a serine protease required for processing of hepatitis C virus polyprotein | Q27486059 | ||
| Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus | Q27486062 | ||
| Structure and organization of the hepatitis C virus genome isolated from human carriers | Q27486168 | ||
| Processing and localization of Dengue virus type 2 polyprotein precursor NS3-NS4A-NS4B-NS5 | Q27486204 | ||
| Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease | Q27486221 | ||
| Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites | Q27486606 | ||
| Genetic organization and diversity of the hepatitis C virus | Q27860507 | ||
| Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis | Q27860603 | ||
| Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 | ||
| Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis | Q27860811 | ||
| An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis | Q27860909 | ||
| Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions | Q29620803 | ||
| Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes | Q29620921 | ||
| Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome | Q29620976 | ||
| Dengue virus-induced modifications of host cell membranes | Q36541432 | ||
| The Taiwanese hepatitis C virus genome: Sequence determination and mapping the 5′ termini of viral genomic and antigenomic RNA | Q42599039 | ||
| Molecular cloning of hepatitis C virus genome from a single Japanese carrier: sequence variation within the same individual and among infected individuals | Q42599376 | ||
| The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor | Q43048247 | ||
| Amino-terminal presequence of the precursor of peroxisomal 3-ketoacyl-CoA thiolase is a cleavable signal peptide for peroxisomal targeting. | Q54687138 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | proteolysis | Q33123 |
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 10773-10777 | |
| P577 | publication date | 1993-11-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus | |
| P478 | volume | 90 |
| Q27480287 | A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro |
| Q35578182 | A conserved NS3 surface patch orchestrates NS2 protease stimulation, NS5A hyperphosphorylation and HCV genome replication |
| Q34120119 | A disulfide-bonded dimer of the core protein of hepatitis C virus is important for virus-like particle production |
| Q42994228 | A high throughput assay of the hepatitis C virus nonstructural protein 3 serine proteinase |
| Q39964799 | A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replication |
| Q41839580 | Acquisition of Genetic Aberrations by Activation-Induced Cytidine Deaminase (AID) during Inflammation-Associated Carcinogenesis |
| Q27470008 | Activation of the interferon-inducible 2'-5'-oligoadenylate synthetase gene by hepatitis C virus core protein |
| Q27480741 | Activity of purified hepatitis C virus protease NS3 on peptide substrates |
| Q28377704 | Alpha-ketoamides, alpha-ketoesters and alpha-diketones as HCV NS3 protease inhibitors |
| Q36056232 | Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression. |
| Q27473477 | Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication |
| Q27485980 | Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2 |
| Q41089053 | Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes |
| Q24323048 | Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A |
| Q27480337 | Binding Dynamics of Hepatitis C Virus' NS5A Amphipathic Peptide to Cell and Model Membranes |
| Q27480890 | Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity |
| Q24531676 | Caspase-mediated cleavage of eukaryotic translation initiation factor subunit 2alpha |
| Q31037469 | Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride |
| Q27485758 | Cell Surface Expression of Major Histocompatibility Complex Class I Molecules Is Reduced in Hepatitis C Virus Subgenomic Replicon-Expressing Cells |
| Q40180818 | Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA. |
| Q50587343 | Characteristics of the hepatitis C virus and viral predictors of therapeutic response |
| Q27469532 | Characterization of an autonomous subgenomic pestivirus RNA replicon |
| Q27469765 | Characterization of cell lines carrying self-replicating hepatitis C virus RNAs |
| Q27480746 | Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2 |
| Q43038680 | Characterization of monoclonal antibodies and epitope mapping of the NS4 protein of hepatitis C virus. |
| Q40543432 | Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts |
| Q41011390 | Characterization of the structural proteins of hepatitis C virus expressed by an adenovirus recombinant |
| Q36724437 | Cholesterol-Enriched Domain Formation Induced by Viral-Encoded, Membrane-Active Amphipathic Peptide. |
| Q41056018 | Clinical relevance of hepatitis C virus quasispecies |
| Q31043920 | Cloning and molecular characterization of human high affinity antibody fragments against Hepatitis C virus NS3 helicase |
| Q40425026 | Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells |
| Q27478292 | Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region |
| Q27469609 | Complete translation of the hepatitis C virus genome in vitro: membranes play a critical role in the maturation of all virus proteins except for NS3. |
| Q40344510 | Complex formation between hepatitis C virus NS2 and NS3 proteins |
| Q27480317 | Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation |
| Q27484186 | Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: A 2.2 Å resolution structure in a hexagonal crystal form |
| Q36942703 | Conserved C-terminal threonine of hepatitis C virus NS3 regulates autoproteolysis and prevents product inhibition |
| Q42241797 | Construction of a chimeric hepatitis C virus replicon based on a strain isolated from a chronic hepatitis C patient |
| Q27733707 | Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide |
| Q38327973 | Dengue virus NS3 serine protease. Crystal structure and insights into interaction of the active site with substrates by molecular modeling and structural analysis of mutational effects |
| Q41785165 | Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies. |
| Q33826766 | Development of an intergenotypic hepatitis C virus (HCV) cell culture method to assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1 to 6 |
| Q40627485 | Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element. |
| Q37942777 | Discovery of hepatitis C virus NS5A inhibitors as a new class of anti-HCV therapy |
| Q39862987 | Double-stranded RNA-induced interferon-beta and inflammatory cytokine production modulated by hepatitis C virus serine proteases derived from patients with hepatic diseases |
| Q40584601 | Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon |
| Q43036511 | Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells |
| Q39951846 | Effects of silymarin on hepatitis C virus and haem oxygenase-1 gene expression in human hepatoma cells |
| Q39805946 | Efficient replication systems for hepatitis C virus using a new human hepatoma cell line |
| Q45440609 | Emerging therapies for hepatitis C virus infection |
| Q42992970 | Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization |
| Q37242521 | Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen |
| Q27480392 | Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system |
| Q31146715 | Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro |
| Q43035190 | Evaluation of complete genome sequences and sequences of individual gene products for the classification of hepatitis C viruses |
| Q27485996 | Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses |
| Q27485921 | Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection |
| Q56480896 | Genotyping & diagnostic methods for hepatitis C virus: A need of low-resource countries |
| Q57432962 | Hepatitis C |
| Q38292825 | Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity |
| Q34429108 | Hepatitis C virus NS2/3 processing is required for NS3 stability and viral RNA replication |
| Q24309078 | Hepatitis C virus NS3 protein interacts with ELKS-{delta} and ELKS-{alpha}, members of a novel protein family involved in intracellular transport and secretory pathways |
| Q27486009 | Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics |
| Q38795132 | Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response. |
| Q39821567 | Hepatitis C virus NS4B induces unfolded protein response and endoplasmic reticulum overload response-dependent NF-kappaB activation |
| Q45758885 | Hepatitis C virus NS5A protein is phosphorylated in vitro by a stably bound protein kinase from HeLa cells and by cAMP-dependent protein kinase A-alpha catalytic subunit |
| Q42999825 | Hepatitis C virus NS5B RNA replicase specifically binds ribosomes |
| Q22010735 | Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein |
| Q39594009 | Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation |
| Q27478331 | Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor expression via activation of nuclear factor- B |
| Q27480329 | Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin |
| Q30155561 | Hepatitis C virus hijacks P-body and stress granule components around lipid droplets |
| Q39610357 | Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins |
| Q24300867 | Hepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activity |
| Q40636299 | Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication |
| Q27478479 | Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells |
| Q27486011 | Hepatitis C virus polyprotein processing: kinetics and mutagenic analysis of serine proteinase-dependent cleavage |
| Q24537844 | Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway |
| Q40590374 | Hepatitis C virus suppresses the IRE1-XBP1 pathway of the unfolded protein response |
| Q35147050 | Hepatitis C virus therapies: current treatments, targets and future perspectives |
| Q27480276 | Hepatitis C virus-encoded NS2-3 protease: cleavage-site mutagenesis and requirements for bimolecular cleavage |
| Q27478455 | Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing |
| Q27468561 | Human Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex Formation |
| Q42988935 | Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein |
| Q33933056 | Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. |
| Q41001137 | Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus |
| Q27469751 | Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein |
| Q24295396 | Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS5A protein |
| Q24338469 | Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein |
| Q39349765 | Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA. |
| Q27480323 | Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease |
| Q41215982 | In vitro activity of hepatitis C virus protease NS3 purified from recombinant Baculovirus-infected Sf9 cells |
| Q43034797 | In vitro characterization of a purified NS2/3 protease variant of hepatitis C virus |
| Q42982898 | In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms |
| Q42994273 | In vitro studies of cross-resistance mutations against two hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061. |
| Q27480845 | In vitro study of the NS2-3 protease of hepatitis C virus |
| Q28377012 | Inhibition of hepatitis C virus NS2/3 processing by NS4A peptides. Implications for control of viral processing |
| Q43035640 | Inhibition of hepatitis C virus NS3 function by antisense oligodeoxynucleotides and protease inhibitor |
| Q27480410 | Interaction between hepatitis C virus core protein and E1 envelope protein |
| Q24600344 | Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft |
| Q27469554 | Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations |
| Q49787914 | Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling. |
| Q21560973 | Intrinsically unstructured domain 3 of hepatitis C Virus NS5A forms a "fuzzy complex" with VAPB-MSP domain which carries ALS-causing mutations |
| Q33616812 | Involvement of DNA damage response pathways in hepatocellular carcinoma |
| Q40000685 | Isolation and gene analysis of interferon alpha-resistant cell clones of the hepatitis C virus subgenome |
| Q24648164 | Kinetic and structural analyses of hepatitis C virus polyprotein processing |
| Q40103042 | Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes |
| Q41248646 | Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy |
| Q42986639 | Modification of hepatitis C virus 1b RNA polymerase to make a highly active JFH1-type polymerase by mutation of the thumb domain. |
| Q27469363 | Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A, and NS4B |
| Q35832747 | Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation |
| Q33983949 | Molecular biology of hepatitis C infection |
| Q36900138 | Molecular biology of hepatitis C virus |
| Q27469559 | Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus |
| Q38299880 | Multiple functions of DDX3 RNA helicase in gene regulation, tumorigenesis, and viral infection |
| Q42984013 | Mutational Analysis of Hepatitis C Virus NS5B in the Subgenomic Replicon Cell Culture |
| Q21245104 | NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b |
| Q38638651 | New directions for protease inhibitors directed drug discovery |
| Q27691438 | New insights into HCV replication: potential antiviral targets. |
| Q29620681 | Novel insights into hepatitis C virus replication and persistence |
| Q27485919 | Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus |
| Q44705788 | Peptide inhibitors of hepatitis C virus NS3 protease |
| Q27470294 | Persistence of bovine viral diarrhea virus is determined by a cellular cofactor of a viral autoprotease |
| Q27645411 | Phenotypic and structural analyses of hepatitis C virus NS3 protease Arg155 variants: sensitivity to telaprevir (VX-950) and interferon alpha |
| Q35115608 | Phosphatidylserine-specific phospholipase A1 involved in hepatitis C virus assembly through NS2 complex formation |
| Q34003264 | Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication? |
| Q27478481 | Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A |
| Q27480873 | Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase |
| Q27480818 | Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells |
| Q40773880 | Post-translational modification of the hepatitis C virus core protein by tissue transglutaminase |
| Q37408926 | Post-translational modifications of hepatitis C viral proteins and their biological significance |
| Q27679235 | Preclinical Characterization of JTK-853, a Novel Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase |
| Q27485927 | Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini |
| Q35143996 | Prominent steatosis with hypermetabolism of the cell line permissive for years of infection with hepatitis C virus |
| Q41925282 | Protein Inhibitor of Activated STAT2 Restricts HCV Replication by Modulating Viral Proteins Degradation |
| Q27473469 | Protein-Protein Interactions between Hepatitis C Virus Nonstructural Proteins |
| Q33818878 | RNA polymerase activity and specific RNA structure are required for efficient HCV replication in cultured cells |
| Q42060448 | RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region |
| Q24300700 | Raf-1 kinase associates with Hepatitis C virus NS5A and regulates viral replication |
| Q43037298 | Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo |
| Q42991702 | Rational design and functional expression of a constitutively active single-chain NS4A-NS3 proteinase |
| Q74489926 | Recent advances in prevention and treatment of hepatitis C virus infections |
| Q35122644 | Regulatory mechanisms of viral hepatitis B and C |
| Q41179886 | Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes |
| Q40436570 | Role of La autoantigen and polypyrimidine tract-binding protein in HCV replication |
| Q27469697 | Roles of the AX(4)GKS and arginine-rich motifs of hepatitis C virus RNA helicase in ATP- and viral RNA-binding activity |
| Q51792142 | Searching for discrimination rules in protease proteolytic cleavage activity using genetic programming with a min-max scoring function. |
| Q27469337 | Selection of functional variants of the NS3-NS4A protease of hepatitis C virus by using chimeric sindbis viruses |
| Q42992982 | Selective stimulation of hepatitis C virus and pestivirus NS5B RNA polymerase activity by GTP. |
| Q36871226 | Selectively infective phages (SIP). |
| Q40176702 | Serum-free cell culture system supplemented with lipid-rich albumin for hepatitis C virus (strain O of genotype 1b) replication |
| Q43037798 | Structural and functional comparison of the non-structural protein 4B in flaviviridae |
| Q40727114 | Subgenomic replicon derived from a cell line infected with the hepatitis C virus |
| Q27478443 | Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase |
| Q27486002 | Substrate requirements of hepatitis C virus serine proteinase for intermolecular polypeptide cleavage in Escherichia coli |
| Q45764108 | Substrate specificity of the hepatitis C virus serine protease NS3. |
| Q39712899 | TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION. |
| Q40181096 | Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytes |
| Q35115534 | Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus |
| Q37945210 | The Hepatitis C Virus Nonstructural Protein 2 (NS2): An Up-and-Coming Antiviral Drug Target |
| Q27480286 | The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A |
| Q27480777 | The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation |
| Q27480316 | The NS2 protein of hepatitis C virus is a transmembrane polypeptide |
| Q27481011 | The NS3 Helicase and NS5B-to-3'X Regions Are Important for Efficient Hepatitis C Virus Strain JFH-1 Replication in Huh7 Cells |
| Q27480807 | The NS3 proteinase domain of hepatitis C virus is a zinc-containing enzyme |
| Q33801327 | The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy |
| Q36740829 | The anti-genomic (negative) strand of Hepatitis C Virus is not targetable by shRNA. |
| Q33993109 | The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay |
| Q39554467 | The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein |
| Q27490490 | The hepatitis C virus non-structural NS5A protein impairs both the innate and adaptive hepatic immune response in vivo |
| Q30667774 | The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein |
| Q34210660 | The molecular biology of hepatitis C virus. Genotypes and quasispecies |
| Q27469583 | The native form and maturation process of hepatitis C virus core protein |
| Q33801346 | The non-structural 5A protein of hepatitis C virus |
| Q38668968 | The role of HCV proteins on treatment outcomes |
| Q27473470 | Topology of the Membrane-Associated Hepatitis C Virus Protein NS4B |
| Q40376486 | Trans-complementation of HCV replication by non-structural protein 5A. |
| Q27485998 | Two hepatitis C virus glycoprotein E2 products with different C termini |
| Q38218108 | Unfolded protein response in hepatitis C virus infection |
| Q27480326 | Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region |
| Q30155273 | VAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5B. |
| Q27473228 | VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon Cells |
| Q40221698 | Zinc is a negative regulator of hepatitis C virus RNA replication. |
| Q40487547 | cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells |
Search more.